Zobrazeno 1 - 10
of 60
pro vyhledávání: '"D. A. Veber"'
Publikováno v:
Омский научный вестник: Серия "Авиационно-ракетное и энергетическое машиностроение", Vol 7, Iss 4, Pp 79-84 (2023)
One of the tasks of polymer materials science is to study the possibilities of improving the complex of elastic-strength characteristics and tribological properties of polymer composite materials by improving the manufacturing technology. In this p
Externí odkaz:
https://doaj.org/article/300b36040228437dacdd62947f60b59f
Autor:
K.J. Stauffer, Jules A. Shafer, Stephen F. Brady, S. D. Lewis, John T. Sisko, D. F. Veber, Howard Qiu, Assunta S. Ng, Ruth F. Nutt, Michael J. Bogusky, Christiana D. Colton
Publikováno v:
Bioorganic & Medicinal Chemistry. 3:1063-1078
We report structure-activity investigations in a series of tripeptide amide inhibitors of thrombin, and the development of a series of highly potent active site directed α-keto carbonyl inhibitors having the side chain of lysine at P1. Compounds of
Autor:
Thomas F. Walsh, Nancy A. Nolan, Douglas J. Pettibone, William J. Greenlee, Stacey O'Malley, Raymond S.L. Chang, Kenneth J. Fitch, D. F. Veber, David L. Williams, Kathryn L. Murphy, Bradley V. Clineschmidt
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:1155-1158
Screening a collection of α-phenoxyphenylacetic acid derived angiotensin II antagonists identified weak actives in an endothelin receptor binding assay. Synthetic modification of one of these leads has provided L-746,072 (13), a highly potent dual a
Autor:
N. P. Gould, James B. Hoffman, D. F. Veber, Doug W. Hobbs, Doug J. Pettibone, Roger M. Freidinger, Bradley V. Clineschmidt
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:119-122
The structure activity relationships of a series of non-peptide oxytocin antagonists containing a camphor aminosuccinimide as a key structural element were investigated. A potent and selective analog was identified and prepared in diastereomerically
Autor:
Alison J. Smith, D. F. Veber, Robert M. DiPardo, Randall C. Newton, Kerry L. Chapman, Smita Patel, Mark G. Bock, Jeffrey M. Bergman, Roger M. Freidinger, George R. Marshall, John A. Kemp, Stephen B. Freedman
Publikováno v:
Bioorganic & Medicinal Chemistry. 2:987-998
A series of imidazobenzodiazepines, non-peptide antagonists of the peptide hormone cholecystokinin (CCK), are described. Derived by chemical modification of the benzodiazepine ring system embedded within the CCK-B antagonist L-365,260, these compound
Autor:
C. J. Woyden, M. J. Novy, Mark G. Bock, Bradley V. Clineschmidt, B. E. Evans, E V Lis, Terry W. Schorn, K. L. Thompson, Peter K. S. Siegl, Douglas J. Pettibone, Duane R. Reiss, Peter D. Williams, Doug W. Hobbs, M. A. Cukierski, Maribeth T. Guidotti, Roger M. Freidinger, D. F. Veber, G. J. Haluska, M. J. Cook, M. J. Kaufman, S.-H. L. Chiu
Publikováno v:
Drug Development Research. 30:129-142
L-368,899 [1S-(-7,7-dimethyl-2-endo-(2S-amino-4-(methylsulfonyl)butyramido)-bicyclo(2.2.1)-heptan-1-yl)methanesulfonyl)-4-(2-methylphenyl)piperazine] was characterized in vitro and in vivo as a potent and selective, orally bioavailable oxytocin (OT)
Autor:
D. F. Veber, Steven M. Pitzenberger, Stephen F. Brady, Christiane D. Colton, Michael E. Mertzman, Michael J. Bogusky, Ruth F. Nutt, Adel M. Naylor
Publikováno v:
Biopolymers. 33:1287-1297
The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonist, was characterized in DMSO-d6 by the combination of nmr and molecular modeling. The conformational space available to the peptide was explored using a dis
Autor:
Mark G. Bock, Stephen B. Freedman, Robert M. DiPardo, Victor J. Lotti, Raymond S.L. Chang, Roger M. Freidinger, D. F. Veber
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:871-874
A series of 1,3-substituted benzolactams are reported which are nonpeptidal receptor ligands of the peptide hormone cholecystokinin (CCK). These compounds are composites of potent, selective benzolactam CCK-A antagonists and unique structural element
Autor:
Mark G. Bock, B. E. Evans, Peter D. Williams, Roger M. Freidinger, Douglas J. Pettibone, D. F. Veber, Bradley V. Clineschmidt
Publikováno v:
Regulatory Peptides. 45:289-293
Autor:
Richard Saperstein, Terry Reisine, Byron H. Arison, William J. Paleveda, Roger M. Freidinger, Edward J. Brady, Stephen F. Brady, Karen Raynor, D. F. Veber
Publikováno v:
Tetrahedron. 49:3449-3466
In testing and refining our model of the receptor-bound conformation of the potent small-ring somatostatin analog cyclo-(Pro6-Phe7-D-Trp8-Lys9-Thr10-Phe11), we have investigated structures constrained within bicyclic systems. Specifically, we have in